LMR Partners »

Cytokinetics shares owned by LMR Partners

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by LMR Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.2M 175k 52.80
2024-03-31 $351k 5.0k 70.11
2023-12-31 $34M 410k 83.49
2017-03-31 $158k 12k 13.03

More positions owned by LMR Partners

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Put Option (NVDA)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Microstrategy Cl A New (MSTR)
Advanced Micro Devices Put Option (AMD)
Capri Holdings SHS Call Option (CPRI)
Tesla Motors (TSLA)
Apple Put Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Endeavor Group Hldgs Cl A Com (EDR)
Microsoft Corporation (MSFT)
Moderna (MRNA)
Albertsons Cos Common Stock Call Option (ACI)
Dish Network Corporation Note 3.375% 8/1 (Principal)

View all positions for LMR Partners

Top funds holding Cytokinetics

BlackRock
FMR
Vanguard Group
T. Rowe Price Investment Management
Wellington Management Company
State Street Corporation
Bank of America Corporation
Armistice Capital
T. Rowe Price Associates
Geode Capital Management
Rtw Investments
Polar Capital Holdings
Pentwater Capital Management
Boxer Capital
Pictet Asset Management Holding SA

View all funds holding Cytokinetics